|
METT10D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.966800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.433200E-01 |
| Normal-vs-Stage2 |
8.030000E-01 |
| Normal-vs-Stage3 |
4.521100E-03 |
| Normal-vs-Stage4 |
1.099480E-03 |
| Stage1-vs-Stage2 |
3.573400E-01 |
| Stage1-vs-Stage3 |
8.08389999999992E-05 |
| Stage1-vs-Stage4 |
3.4422000000367E-06 |
| Stage2-vs-Stage3 |
6.238000E-02 |
| Stage2-vs-Stage4 |
3.324000E-02 |
| Stage3-vs-Stage4 |
5.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.124800E-01 |
| Normal-vs-AfricanAmerican |
9.606800E-01 |
| Normal-vs-Asian |
2.420200E-01 |
| Caucasian-vs-AfricanAmerican |
4.401800E-01 |
| Caucasian-vs-Asian |
2.359200E-01 |
| AfricanAmerican-vs-Asian |
4.404000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.580300E-02 |
| Normal-vs-Female |
7.398600E-01 |
| Male-vs-Female |
2.241500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.503800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.205600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.997800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.474840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.121390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.902240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.983000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.763200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.388150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.219200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.795490E-03 |
| Normal-vs-Grade 2 |
2.293400E-01 |
| Normal-vs-Grade 3 |
1.919770E-02 |
| Normal-vs-Grade 4 |
8.35650000000632E-05 |
| Grade 1-vs-Grade 2 |
6.063600E-02 |
| Grade 1-vs-Grade 3 |
3.014400E-04 |
| Grade 1-vs-Grade 4 |
2.12109999997434E-06 |
| Grade 2-vs-Grade 3 |
6.46939999999763E-05 |
| Grade 2-vs-Grade 4 |
9.75709999462282E-08 |
| Grade 3-vs-Grade 4 |
2.454000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.904300E-02 |
| Normal-vs-ccB subtype |
2.563700E-03 |
| ccA subtype-vs-ccB subtype |
6.73889999358579E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.812800E-01 |
| Normal-vs-N1 |
2.569800E-01 |
| N0-vs-N1 |
5.902400E-01 |
|
|
